The effectiveness of this insider-resale shelf, combined with Tevogen's minimal cash runway and negative equity, likely signals near-term selling by The Patel Family, LLP. Traders should monitor for a takedown notice or Form 4 filings.
Price Chart
Executive Summary
Tevogen Bio's S-3 shelf registration (File No. 333-296760) became effective on June 25, 2026, enabling the resale of up to 375,000 common shares by insider The Patel Family, LLP. The company receives no proceeds from this resale, and with only $692k cash and a $9.8M stockholders' deficit as of March 31, 2026, the effectiveness signals imminent insider selling pressure on a micro-cap stock with a $40M market cap.
Key Facts
- Shelf registration (333-296760) declared effective by SEC on June 25, 2026.
- Covers up to 375,000 common shares for resale by The Patel Family, LLP, an insider.
- Company receives no proceeds from the resale offering.
- Prior 10-Q (March 31, 2026) showed only $692k cash, $9.8M stockholders' deficit, and $5.4M quarterly net loss.
- Market cap is approximately $40M with 0% analyst bullish rating (3 Hold, 1 Sell, 2 Strong Sell).
Financial Impact
Up to 375,000 shares available for insider resale; no proceeds to Tevogen. At current market cap of ~$40M, the offering represents a modest but potentially dilutive overhang given the company's precarious cash position.
Risk Factors
- Insider selling pressure from The Patel Family, LLP could depress the stock price.
- Company's cash burn rate ($5.4M/quarter) far exceeds available cash ($692k), raising going-concern risk.
- Zero analyst bullish coverage and negative historical stock momentum increase downside vulnerability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002124 |
| Document: 9999999995-26-002124-index.html | 9999999995-26-002124 |
| Document: 9999999995-26-002124.txt | 9999999995-26-002124 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 8-K | $6.72 | awaiting T+60 | — | $6.25 (−6.99%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.25 (−18.94%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.25 (−18.94%) |
Sep 16, 2026 5w ago | 8-K | $7.71 | awaiting T+60 | — | $6.25 (−18.94%) |
Jun 26, 2026 17w ago | EFFECT | $7.00 $7.43 | ▼ −6.14% | ▼ −1.66% | $6.25 (+10.71%) |
Jun 12, 2026 19w ago | S-3 | $10.02 $7.34 | ▲ +26.75% | ▲ +27.75% | $6.25 (+37.62%) |
Jun 9, 2026 19w ago | Press Release | $10.75 $7.17 | ▼ −33.30% | ▼ −37.12% | $6.25 (−41.86%) |
May 28, 2026 21w ago | Press Release | $8.04 $6.75 | ▼ −16.04% | ▼ −17.78% | $6.25 (−22.26%) |
May 21, 2026 22w ago | Press Release | $11.57 $6.58 | ▼ −43.10% | ▼ −47.40% | $6.25 (−45.96%) |
Mar 25, 2026 30w ago | Press Release | $5.18 $9.79 | ▲ +88.90% | ▲ +75.44% | $6.25 (+20.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers